Wendy future of retail top

Featured Articles

This is a category for posts to be display on top left column

Panzer hails mentorship and collaboration

Panzer hails mentorship and collaboration

PALM BEACH, Fla. — In his first remarks as chairman of the National Association of Chain Drug Stores, Mark Panzer thanked those who have taught and collaborated with him throughout his 46-year retail career. He said that NACDS chain and associate members alike can rely on the same formula of “listen, learn and engage” to

Panzer vows to keep NACDS focused on patients’ needs

Panzer vows to keep NACDS focused on patients’ needs

BOISE, Idaho — Mark Panzer, chairman of the National Association of Chain Drug Stores, has been involved with the chain drug business for over 40 years. During that time, he has seen the industry transformed, above all by consolidation, but also in response to broader changes in retailing and consumer behavior as well as changing

Anderson spurs NACDS to anticipate what comes next

Anderson spurs NACDS to anticipate what comes next

ARLINGTON, Va. — In the currently chaotic public policy environment, the ability of the National Association of Chain Drug Stores to remain both focused and nimble in support of its industry has been a huge asset to the NACDS membership. As NACDS president and chief executive officer Steve Anderson pointed out earlier this year, the

Walgreens pilot brings together new approaches

Walgreens pilot brings together new approaches

GAINESVILLE, Fla. — Walgreens is launching a pilot program here that incorporates new approaches to pricing, promotions, product assortment and service offerings to create a new customer experience. The program, which has been implemented in 17 stores in the Gainesville area, will be monitored over the next 12 to 18 months to gauge customer reaction

Fred’s looks to sell specialty pharmacy business

Fred’s looks to sell specialty pharmacy business

MEMPHIS — Fred’s Inc. has announced plans to sell its specialty pharmacy business. The disclosure led the company to delay publication of its fourth quarter and 2017 full-year results. An earnings call that was slated for today is now expected to be held May 4. A filing yesterday with the Securities and Exchange Commission says

Kevin Hourican named president of CVS Pharmacy

Kevin Hourican named president of CVS Pharmacy

WOONSOCKET, R.I. —  Kevin Hourican has been promoted to president of CVS Pharmacy, the retail division of CVS Health. Hourican, who most recently served as the company’s executive vice president of retail pharmacy, had been serving as interim president of the drug chain following the departure of Helena Foulkes, who left to head Hudson’s Bay Co. In his

Despite red ink, Rite Aid sees some progress

Despite red ink, Rite Aid sees some progress

CAMP HILL, Pa. — Rite Aid Corp. on Thursday reported net income of $767.1 million, or 73 cents per diluted share, for the fourth quarter ended March 3. The company showed a net loss from continuing operations of $483.7 million, or 46 cents per diluted share, for the quarter. Adjusted net loss from continuing operations

CVS Health aims to help patients save

CVS Health aims to help patients save

WOONSOCKET, R.I. — CVS Health has revealed a new, comprehensive program designed to combat rising prescription drug prices and help patients save money on their medications. The new initiatives are being launched against a background of ongoing increases in manufacturers’ list prices for drugs and a growing percentage of Americans who have high-deductible health plans.

CVS to focus on kidney care and dialysis treatment

CVS to focus on kidney care and dialysis treatment

WOONSOCKET, R.I.— CVS Health announced an exciting new initiative that will focus on chronic kidney disease and dialysis and builds upon the company’s focus on driving innovation in the management of chronic disease to help improve patient health outcomes while managing costs. This new program will focus on early identification of kidney disease and expansion of

Walgreens Boots Alliance posts 2Q gains

Walgreens Boots Alliance posts 2Q gains

DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) reported better-than-expected earnings and revenue on Wednesday when it announced results for the second quarter of fiscal 2018, which ended February 28. Overall, WBA earned $1.73 a share, up 27% versus a year ago. Revenue grew 12.1% to $33.02 billion. Same-store sales rose 2.4%, with comparable-pharmacy sales up

1 77 78 79 80 81 119
PP_1170x120_10-25-21